Harvest Investment Services, LLC Myriad Genetics Inc Transaction History

Harvest Investment Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$16.45 - $25.88 $388,516 - $611,233	-23,618 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$22.67 - $28.01 $237,060 - $292,900	-10,457 Reduced 30.69%	23,618 $595,000
Q4 2021 Jan 31, 2022	BUY	$24.13 - $32.63 $234,640 - $317,294	9,724 Added 39.93%	34,075 $940,000
Q3 2021 Oct 29, 2021	BUY	$29.97 - $36.66 $92,667 - $113,352	3,092 Added 14.54%	24,351 $786,000
Q2 2021 Aug 10, 2021	BUY	$25.39 - $32.61 $79,445 - $102,036	3,129 Added 17.26%	21,259 $650,000
Q1 2021 May 06, 2021	BUY	$19.92 - $31.6 $361,149 - $572,908	18,130 New	18,130 $552,000

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.21B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.